Adrenoleukodystrophy (ALD): X‑Linked Inheritance & Reproductive Risk

Adrenoleukodystrophy (ALD) is an X‑linked recessive disorder caused by ABCD1 mutations → impaired very‑long‑chain fatty acid (VLCFA) β‑oxidation → accumulation in brain, adrenal cortex, testes.

Inheritance Patterns

  • Affected male (XY): all daughters = obligate carriers; all sons = unaffected (receive Y).
  • Carrier female (XX): each child (regardless of sex) has 50% chance of inheriting mutant allele.
    • Sons who inherit → affected.
    • Daughters who inherit → carriers (may develop symptoms).

Phenotypic Variability

  • Males: childhood cerebral ALD (CALD, 35%), adrenomyeloneuropathy (AMN, 40–45%), adrenal insufficiency only, asymptomatic.
  • Carrier females: ~50% develop mild‑moderate AMN‑like symptoms (spastic paraparesis, neuropathy) by age 60; rarely cerebral involvement.

Reproductive Options

  • Prenatal diagnosis: chorionic villus sampling (CVS) or amniocentesis for ABCD1 mutation.
  • Preimplantation genetic testing (PGT‑M) with IVF.
  • Sperm donation (if male affected) or egg donation (if female carrier).

Monitoring

  • All males with ABCD1 mutation: annual brain MRI (Loes score), adrenal function (ACTH stimulation), VLCFA levels.
  • Carrier females: periodic neurologic exam, VLCFA.

Genetic Disorders - Related Articles